Ga. Ordway et al., PHARMACOLOGY AND DISTRIBUTION OF NOREPINEPHRINE TRANSPORTERS IN THE HUMAN LOCUS-COERULEUS AND RAPHE NUCLEI, The Journal of neuroscience, 17(5), 1997, pp. 1710-1719
The norepinephrine transporter (NET) is a site of action for tricyclic
antidepressant drugs and for drugs of abuse such as amphetamine and c
ocaine. In this study, the binding of [H-3]nisoxetine to NETs in the n
oradrenergic cell group, the locus coeruleus, and the serotonergic cel
l groups, the dorsal raphe nuclei, was measured autoradiographically i
n postmortem human brain. [H-3]nisoxetine binding was unevenly distrib
uted along the rostral-caudal axis of the locus coeruleus and correlat
ed positively with numbers of neuromelanin-containing (noradrenergic)
cells along the axis of the locus coeruleus within individuals. Bindin
g densities of [H-3]nisoxetine in dorsal raphe nuclei were similar to
that in the locus coeruleus. [H-3]nisoxetine binding was unevenly dist
ributed along the entire rostral-caudal extent of the dorsal raphe, wi
th the highest binding occurring in the interfascicular and ventral nu
clei. A moderate amount of [H-3]nisoxetine binding was also observed i
n the median raphe nucleus. The specificity of [H-3]nisoxetine binding
to NETs in monoaminergic nuclei was assessed by measuring the inhibit
ion of its binding by desipramine, imipramine, or citalopram. The orde
r of affinities of these drugs was identical in the locus coeruleus an
d dorsal and median raphe and was characteristic of binding to NETs (d
esipramine > imipramine > citalopram). Thus, high levels of NETs and a
n uneven distribution of NETs occur in the locus coeruleus as well as
in the dorsal raphe nuclei of the human.